Cilacar 10 (Cilnidipine): Why It Reduces Ankle Edema Compared to Amlodipine
Explore Cilacar 10 (Cilnidipine): dual L-type and N-type calcium channel blocker, lower ankle swelling rates, sympathetic nerve protection, and generic...
Cilacar 10 contains Cilnidipine (10mg), a modern dual L-type and N-type calcium channel blocker. While older drugs like Amlodipine block only L-type channels (causing ankle swelling), Cilnidipine also blocks N-type channels located at sympathetic nerve endings. This dilates both arteries and veins equally, eliminating ankle edema and protecting kidneys from proteinuria.
1. Balanced Arteriolar and Venular Dilation
By dilating efferent renal arterioles and venous capillary beds alongside arteries, Cilnidipine maintains balanced capillary pressure, effectively resolving the swollen feet commonly triggered by amlodipine.
2. Reduction in Proteinuria (Kidney Protection)
Clinical studies demonstrate that Cilnidipine reduces intraglomerular pressure and reduces microalbuminuria in diabetic and hypertensive patients, making it favored by nephrologists.
3. Generic Alternative & Price Analysis
Branded Cilacar 10 costs ~₹145 for 15 tablets. Generic Cilnidipine 10mg is available at Jan Aushadhi Kendras for ₹16.00 for 10 tablets (78% savings).
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Can I switch from Amlodipine to Cilnidipine if my ankles are swollen?
Yes, doctors frequently switch patients from Amlodipine to Cilnidipine specifically to resolve persistent pedal edema.
Q2: Can Cilacar cause a fast pulse or reflex tachycardia?
No. Because it suppresses sympathetic N-type calcium channels, Cilnidipine does not cause the reflex tachycardia often seen with older CCBs.
Q3: What is the clinical danger of abruptly stopping blood pressure medications like Telmisartan or Amlodipine?
Sudden discontinuation of antihypertensives can precipitate acute rebound hypertension, hypertensive encephalopathy, acute coronary syndrome, or cerebrovascular accident. Dose titrations must always be conducted under structured clinical supervision.
Q4: Are Jan Aushadhi generic cardiovascular medicines bioequivalent to branded drugs like Telma 40?
Yes. Jan Aushadhi Telmisartan 40mg and Amlodipine 5mg tablets satisfy CDSCO dissolution, content uniformity, and bioavailability requirements, costing ₹7.50 compared to ₹92.00 for branded retail packages.
Q5: Why are ACE inhibitors and Angiotensin Receptor Blockers (ARBs) contraindicated in pregnancy?
Telmisartan, Losartan, and Enalapril are fetotoxic, causing fetal renal dysgenesis, oligohydramnios, neonatal anuria, and calvarial hypoplasia when administered during the second and third trimesters of pregnancy.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.